3-Year Supporting Data on TAVI in Low-Risk Patients: EVOLUT

Published Date: 08 Mar 2023

3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery

Read Full News

Latest News

The Biology of a Broken Heart

Severe grief can trigger Takotsubo syndrome, a stress-induced heart failure that mimics a heart attack and may raise both short- and long-term mortality risk.

Age Affects Survival and Complications After HeartMate 3

Outcomes of the HeartMate 3 device vary by age, with younger patients showing better survival and less bleeding events and older patients having more infections.

New Hydration Breaks in Soccer: A Real Necessity?

As the 2026 World Cup heads into hot and humid conditions, FIFA’s mandated hydration breaks are drawing both medical support and criticism.

Rising Medication Use May Drive Lower BP, Cholesterol Risks

The decreases in blood pressure and cholesterol in higher income countries are mainly observed in older patients with obesity; obesity’s other effects remain a concern.

Self-Expanding Valves Shine in Small Aortic Annuli

In mostly women with small aortic annuli, self-expanding valves maintained superior hemodynamics and far lower valve dysfunction than balloon-expandable devices at 3 years.

TAVR Matches Surgical Valve Durability at 7 Years

Data on valve durability with transcatheter aortic valve replacement are reassuring at 7 years, with implications for lifetime management in younger patients with aortic stenosis.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Latest News

Severe grief can trigger Takotsubo syndrome, a stress-induced heart failure that mimics a heart attack and may raise both short- and long-term mortality risk.

Outcomes of the HeartMate 3 device vary by age, with younger patients showing better survival and less bleeding events and older patients having more infections.

As the 2026 World Cup heads into hot and humid conditions, FIFA’s mandated hydration breaks are drawing both medical support and criticism.

The decreases in blood pressure and cholesterol in higher income countries are mainly observed in older patients with obesity; obesity’s other effects remain a concern.

In mostly women with small aortic annuli, self-expanding valves maintained superior hemodynamics and far lower valve dysfunction than balloon-expandable devices at 3 years.

Data on valve durability with transcatheter aortic valve replacement are reassuring at 7 years, with implications for lifetime management in younger patients with aortic stenosis.

News All Time

Lower Right Heart Reserve Linked to Worse Shunt Outcomes

In patients with heart failure, a lower TAPSE/PASP ratio is linked to higher rates of cardiovascular death or heart failure hospitalisation after interatrial shunting.

Dapagliflozin Cuts Heart Risk in T2D With Advanced Fibrosis

Dapagliflozin can reduce the risk for major adverse cardiovascular events in patients with T2D at a high risk for advanced liver fibrosis, according to a retrospective study.

CMS Proposes TAVR Coverage Framework

Treating patients with symptomatic aortic stenosis does not require collecting further evidence.

Stopping Aspirin Early May Cut Bleeding Risk After Stents

Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.

Obesity Drives 1 in 7 Polypharmacy Cases in Older US Adults

A US cohort study finds that BMI-defined obesity accounts for approximately 15% of polypharmacy cases among older adults, representing an estimated 3.3 million cases.

Why Men Account for Most Drowning Deaths

Drowning deaths are much more common among men, with overconfidence, alcohol, and open-water exposure emerging as key risk factors.

Recognizing Recurrent MI Risk: Identifying High-Risk Patients and Clinical Consequences

Recognizing Recurrent MI Risk: Identifying High-Risk Patients and Clinical Consequences

From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management

From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Advances in Recurrent MI Management: Current and Emerging P2Y12 Strategies

Advances in Recurrent MI Management: Current and Emerging P2Y12 Strategies

Bridging Evidence and Practice: Closing the Gap to Achieve LDL-C Targets and Reduce ASCVD Risk

Bridging Evidence and Practice: Closing the Gap to Achieve LDL-C Targets and Reduce ASCVD Risk

Changing Paradigms in Paroxysmal Nocturnal Hemoglobinuria: Understanding New Pathways, Clinical Evidence, and Practice Guidelines

Changing Paradigms in Paroxysmal Nocturnal Hemoglobinuria: Understanding New Pathways, Clinical Evidence, and Practice Guidelines

Bridging the Divide in Adult Immunization: Strategies for Vaccine Equity and Confidence

Bridging the Divide in Adult Immunization: Strategies for Vaccine Equity and Confidence

GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication

Real-world data found patients on GLP-1s had lower odds of osteomyelitis, ulcers, and amputation

Diabetes Tied to Higher Death Risk After Solid Organ Transplant

Mortality was worse for those with pre-existing and new-onset diabetes

Visceral Fat and Cardiometabolic Risk Factors; Autoantibodies and IBD

Also in TTHealthWatch: insulin price caps

Recommended News For You

According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.

CAR-T Warning for Secondary Malignancies: Warranted or Not?

Parkinson patient's gait is restored by a spinal cord stimulator.

Specific suicidal patterns mark the highest risk.

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

Researchers discover that children who survive cancer have socioeconomic challenges.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

Recommended Articles For You

Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars 

Practical Applications in Hematology Across Clinical Settings 

Unveiling the Mystery Behind Lymphovascular Invasion 

Childhood Cancer Survivorship and Long-Term Organ Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

2.

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

3.

Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer

4.

Alkem introduces cetuximab under the trade name Cetuxa in India.

5.

A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

1.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

2.

Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment

3.

The Benefits and Side Effects of Vidaza Syndrome 

4.

Exploring Innovative Approaches to Esophageal Cancer Treatment

5.

Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

3.

Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment

4.

Navigating the Complexities of Ph Negative ALL - Part XV

5.

Navigating the Complexities of Ph Negative ALL - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot